COVID

This study was designed to test whether an inhaled drug called ZYESAMI could help people with severe COVID-19 avoid getting worse and needing a ventilator. It was a Phase 3 trial, meaning it was in the final stage of testing. However, the study was withdrawn before any participan…

This study planned to give blood plasma from recovered COVID-19 patients to people in the ICU with severe COVID-19. The goal was to see if it could help them breathe better and survive. However, the trial was withdrawn before enrolling any participants, so no results are availabl…

This study aimed to see if the drug sarilumab could help hospitalized COVID-19 patients with severe breathing distress. It planned to compare one or two doses of sarilumab against a placebo. However, the study was withdrawn before enrolling any participants, so no results are ava…

Researchers are studying whether SARS-CoV-2, the virus that causes COVID-19, can be found in the stool of infected patients. They will collect stool samples from 250 adults who tested positive for COVID-19 within the past week and sequence the gut bacteria in those samples. The g…

This nationwide study follows thousands of pregnant women from early pregnancy through the first year of their baby's life to understand how COVID-19 infection affects both mother and child. Researchers will track infections, including those without symptoms, and compare pregnanc…

This study follows 90 people who survived severe COVID-19 pneumonia and needed intensive care. Researchers will check their physical health, mental health, and quality of life at 3 months, 6 months, 1 year, and 5 years after leaving the ICU. The goal is to better understand the l…

This study collects blood samples and medical information from 201 adults diagnosed with COVID-19. The goal is to create a resource that researchers can use to study the virus and improve understanding of the disease. Participants provide samples and allow their health data to be…